Literature DB >> 10469281

Renal chloride channel, CLCN5, mutations in Dent's disease.

J P Cox1, K Yamamoto, P T Christie, C Wooding, T Feest, F A Flinter, P R Goodyer, E Leumann, T Neuhaus, C Reid, P F Williams, O Wrong, R V Thakker.   

Abstract

Dent's disease is an X-linked renal tubular disorder characterized by low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and renal failure. Patients with Dent's disease may also suffer from rickets and other features of the renal Fanconi Syndrome. Patients may have mutations in the X-linked renal chloride channel gene, CLCN5, which encodes a 746-amino-acid protein with 12-13 transmembrane domains. We have investigated the 11 coding exons of CLCN5 for mutations in eight unrelated patients with Dent's disease. Leukocyte DNA was used for the polymerase chain reaction amplification of CLCN5 and the products analyzed for single-stranded conformational polymorphisms (SSCPs). Abnormal SSCPs were sequenced and revealed eight mutations. These consisted of three nonsense mutations (Arg34Stop, Arg648Stop, Arg704Stop), four deletions involving codons 40, 86, 157, and 241, and one acceptor splice consensus sequence mutation tgcag --> tgaag. The mutations were confirmed either by restriction endonuclease or sequence-specific oligonucleotide hybridization analysis. In addition, an analysis of 110 alleles from 74 unrelated normal individuals demonstrated that the DNA sequence changes were not common polymorphisms. All of the mutations predict truncated chloride channels that are likely to result in a functional loss. Thus, our findings expand the spectrum of CLCN5 mutations associated with Dent's disease and the results will help to elucidate further the functional domains of this novel chloride channel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469281     DOI: 10.1359/jbmr.1999.14.9.1536

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization.

Authors:  Michael Ludwig; Jolanta Doroszewicz; Hannsjörg W Seyberth; Arend Bökenkamp; Bernd Balluch; Matti Nuutinen; Boris Utsch; Siegfried Waldegger
Journal:  Hum Genet       Date:  2005-05-14       Impact factor: 4.132

3.  Hypercalciuria in patients with CLCN5 mutations.

Authors:  Michael Ludwig; Boris Utsch; Bernd Balluch; Stefan Fründ; Eberhard Kuwertz-Bröking; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

4.  Dent's disease: clinical features and molecular basis.

Authors:  Félix Claverie-Martín; Elena Ramos-Trujillo; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2010-10-10       Impact factor: 3.714

5.  A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.

Authors:  Gilbert Q Martinez; Merritt Maduke
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

6.  Functional analysis of suspected splicing variants in CLCN5 gene in Dent disease 1.

Authors:  Tomohiko Inoue; China Nagano; Masafumi Matsuo; Tomohiko Yamamura; Nana Sakakibara; Tomoko Horinouchi; Yugo Shibagaki; Daisuke Ichikawa; Yuya Aoto; Shinya Ishiko; Shingo Ishimori; Rini Rossanti; Kazumoto Iijima; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2020-03-22       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.